Collateral Ligament Stabilizer System Market Opportunities, Drivers, Restraints, Threats, Trends, Applications And Growth Forecast To 2018 - 2026
Collateral Ligament Stabilizer System Market |
The lateral collateral ligament connects the femur to the smaller bone in the lower leg, while the medial collateral ligament connects the femur to the tibia on the sides of the knees. Though they can be injured by knee activity, it controls the side motion of the knee and prevents it from unusual movement. A noncontact injury, such as hyperextension stress, can also harm it. Pain, instability of the knee during walking, and swelling are common symptoms when other ligaments of the knee are also affected. Various stress tests are used to measure the ligament's looseness in order to diagnose collateral ligament injury. A magnetic resonance imaging (MRI) scan is also required for diagnosis, and significant ligament rips or ruptures necessitate surgery.
Concerns about the incidence of chronic disorders among the senior population, which is predicted to increase in the coming years, are driving high-end demand for collateral ligament stabiliser systems (CLSS). Similarly, the senior population is experiencing an increase in arthritis and joint diseases as a result of weakening knee ligaments as they age, making them more susceptible to injury. In the next years, such factors are expected to fuel the growth of the Collateral Ligament Stabiliser System Market.
Market Segmentation:
By Ligament Type
By Injury Type
By End User:
According to reports published by the Centers for Disease Control and Prevention, an estimated 78.4 million adults aged 18 years and older will be diagnosed with arthritis in the United States by the year 2040, which is expected to increase the number of cases of collateral ligament stabiliser system.
Some key players are DePuy Synthes, Arthrex, Bauerfeind, DJO Global LLC, and DeRoyal Industries Inc.
By Ligament Type
- Medial Collateral Ligament
- Lateral Collateral Ligament
By Injury Type
- Grade I
- Grade II
- Grade III
By End User:
- Hospitals
- Orthopedic Clinics
According to reports published by the Centers for Disease Control and Prevention, an estimated 78.4 million adults aged 18 years and older will be diagnosed with arthritis in the United States by the year 2040, which is expected to increase the number of cases of collateral ligament stabiliser system.
Some key players are DePuy Synthes, Arthrex, Bauerfeind, DJO Global LLC, and DeRoyal Industries Inc.
Comments
Post a Comment